Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
NCT07352228Phase 4Enrolling by invitation
- Sponsor
- Xijing Hospital
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in Variceal bleeding, sponsored by Xijing Hospital. Started Jan 2026; status: enrolling by invitation.
02
Drugs
carvedilol
03
Conditions
Variceal bleeding
Beyond the preview
Go deeper on NCT07352228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352228.